Guorui Life (00108.HK) successfully completed the strategic acquisition of Chunyu Doctor, with Huaxing Capital acting as the buyer's financial advisor | Huaxing Deal

Follow the Huaxing Capital WeChat Official Account (ID: iChinaRenaissance) for more company information.

On March 11, 2026, Guorui Life (00108.HK), a company listed on the Hong Kong Stock Exchange, officially announced the completion of the strategic acquisition of Chunyu Doctor, a leading enterprise in China’s mobile healthcare sector. After this transaction, Guorui Life will hold approximately 78.3% of Chunyu Doctor’s shares.Huaxing Capital acted as the buyer’s financial advisor for this controlling equity transfer deal.

·CR DEALS

Following this transaction, Guorui Life will enter a new development phase driven by a dual focus on 'space services and health services.' Leveraging Guorui Life’s offline resource advantages and Chunyu Doctor’s accumulated online healthcare ecosystem, they will create comprehensive, full-scenario health living solutions for users, redefining a new business model for residential health services.

Guorui Life has been deeply involved in property development, investment, and management for many years, with operations spanning mainland China, the United States, the United Kingdom, and other regions. It boasts strong offline scenario operation capabilities, a large base of community users, and a mature offline service network. As a pioneer in China’s mobile healthcare industry, Chunyu Doctor has consistently focused on empowering medical services through technology since its establishment. It has built a multi-dimensional online healthcare ecosystem covering online consultations, health education, chronic disease management, and health product e-commerce, amassing massive user data, professional doctor resources, and advanced digital healthcare capabilities. This partnership will integrate Chunyu Doctor’s online medical technology capabilities with Guorui Life’s offline residential resources, bringing professional health management services directly into communities and closer to users, redefining a new business model for residential health services.

Upon completion of this strategic acquisition, Guorui Life will implement a strategy of independent operation and empowerment for Chunyu Doctor, retaining its core team and brand advantages while investing premium resources to further enhance its development. Guorui Life will focus on key vertical specialized medical services, medical research and digital marketing services, home-based medical rehabilitation and long-term care, as well as city-level AI health services. The company will steadily promote the integration of subsequent resources to build an integrated digital healthcare ecosystem both online and offline. Leveraging Chunyu Doctor's medical resources and service capabilities, combined with its own scenario and channel advantages, Guorui Life will provide users with more comprehensive, precise, and convenient health management services, capturing the high ground in industry development.

He Mu, Partner at the Investment Banking Division of Huaxing Capitalstated: "We are extremely honored to have participated fully and witnessed the smooth completion of this landmark M&A transaction within the industry. Huaxing Capital has deeply covered the digital healthcare sector for a long time, having previously successfully led and facilitated important industry M&A transactions such as the strategic sale of Haodafu, Alibaba’s acquisition of Xiaolu Traditional Chinese Medicine, and the strategic merger between Pengsu Doctor and Xingren Doctor. We highly recognize the vast future prospects and transformative potential of AI-driven digital healthcare. As a pioneer in China's online healthcare field, Chunyu Doctor possesses mature digital medical service capabilities and commercialization pathways; whereas Guorui Life, as an outstanding comprehensive urban operation and asset management enterprise, has profound expertise in cross-sector resource integration and refined operations. We firmly believe that this acquisition will lead to deep integration and mutually beneficial cooperation between the two parties. Going forward, Huaxing Capital will continue to delve into various vertical fields, including healthcare, from a strategic perspective while focusing on transactions, continuously contributing to the strategic upgrades and leapfrog development of excellent enterprises."

Disclaimer: This article was written by Huaxing Capital for reference purposes only. It should not be considered a research report on any securities in any jurisdiction, nor does it constitute an invitation or guarantee to buy, sell, or subscribe to securities or other financial instruments and products. Readers should not rely solely on this article but should make investment decisions based on their own judgment and seek professional advice before taking any investment action. Huaxing Capital makes no representations or warranties regarding the content of this article and assumes no responsibility for any consequences arising from the use, misuse, reliance, distribution, or possession of this article.

16K Views